Snell, Cameron E <br/><br/>
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.  [electronic resource] 

 -  Journal of clinical pathology  Nov 2017 
 - 954-960 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1472-4146 
<br/><br/><label>Standard No.: </label>10.1136/jclinpath-2016-204304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aromatase Inhibitors--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--chemistry<br/>Chemotherapy, Adjuvant<br/>Disease-Free Survival<br/>Estrogen Antagonists--therapeutic use<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Lymph Nodes--chemistry<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Queensland<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Retrospective Studies<br/>Risk Factors<br/>Tamoxifen--therapeutic use<br/>Time Factors<br/>Tissue Array Analysis<br/>Treatment Outcome